Covid19
Novavax says COVID-19 shot 80% effective in adolescent study | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/TX4P5GN55VLGXP2HPGN76DZEKM.jpg)
Novavax Inc said on Thursday its two-dose vaccine was 80% effective against COVID-19 in a late-stage trial testing the shot in teens aged 12 to 17 …
Novavax Inc said on Thursday its two-dose vaccine was 80% effective against COVID-19 in a late-stage trial testing the shot in teens aged 12 to 17 …
